Drug-Screen® Tracer 9 is a lateral flow immunoassay test designed for the qualitative detection of multiple drugs and their metabolites in saliva. This test provides reliable and rapid preliminary results, allowing for effective initial screening of detected substances.

Detected substances and their cut-offs

ABP10, AMP50, BUP10, BZD10, COC10, MET50, MOR/OPI10, MTD30, THC15 

Important
This test provides exclusively a preliminary analytical result. To confirm a positive outcome, a more specific alternative chemical method is required, such as:

• 
  

  
  Gas chromatography/mass spectrometry (GC/MS);
  

  
  


• 
  

  
  Gas chromatography/tandem mass spectrometry (GC/MS/MS);
  

  
  


• 
  

  
  Liquid chromatography/mass spectrometry (LC/MS);
  

  
  


• 
  

  
  Liquid chromatography/tandem mass spectrometry (LC/MS/MS).
  

  
  

Professional judgment is essential for interpreting results, especially for preliminary positive ones.

Product Advantages

• 
  

  
  Integrated control: the test coloration indicates when a sufficient amount of saliva has been collected.
  

  
  


• 
  

  
  Analytical precision: detection of THC and its metabolites for greater accuracy.
  

  
  


• 
  

  
  Maximum hygiene: no direct contact with saliva, thanks to the slider that securely seals the sample.
  

  
  

Technical Features

• 
  

  
  Rapid saliva screening test that can be performed without additional devices.
  

  
  


• 
  

  
  Use of monoclonal antibodies for selective and precise detection.
  

  
  


• 
  

  
  Results available in about 10 minutes.
  

  
  


• 
  

  
  Optimal storage at temperatures between 2 - 30°C.
  

  
  


• 
  

  
  Available in packs of 10
  

  
  


• 
  

  
  CE certified for safety and reliability.
  

  
  

The Nal von Minden Drug-Screen® Tracer 9 represents a reliable and hygienic solution for monitoring substance abuse, offering a quick and easy-to-use initial analysis.